From the Guidelines
To use Sebco, or more specifically selenium sulfide, for the treatment of blepharitis, particularly meibomian gland dysfunction (MGD), it is essential to follow a regimen that may involve applying the treatment to the eyelids, potentially as part of a broader treatment plan including warm compresses and eyelid cleansing. The use of selenium sulfide is based on its ability to induce sebum production and its keratolytic and keratostatic effects, which can help in unblocking the meibomian gland orifices and decreasing meibum viscosity 1. When considering treatment options for blepharitis, it's crucial to evaluate the severity of the condition and the patient's response to different treatments.
- Topical treatments such as selenium sulfide, topical antibiotics (like bacitracin or erythromycin), and even oral tetracyclines for more severe cases, especially those involving meibomian gland dysfunction, can be considered.
- The application of warm compresses and eyelid cleansing is often recommended as a long-term management strategy because symptoms can recur when treatment is discontinued 1.
- It's also important to note that treatments like topical perfluorohexyloctane, which prevents tear evaporation, can improve symptoms and corneal staining in patients with dry eye disease, a condition often associated with blepharitis 1. Given the potential side effects and interactions of various treatments, such as tetracyclines causing photosensitization or gastrointestinal upset, and the contraindications in pregnancy, nursing women, and children under 8 years of age, careful consideration and monitoring are necessary 1. The most effective approach to using Sebco or similar treatments for blepharitis involves a comprehensive treatment plan that may include mechanical eyelid cleansing, warm compresses, and potentially topical or oral medications, tailored to the individual's condition and response to treatment.
From the Research
Using Sebco
There are no research papers to assist in answering this question. The provided studies do not mention "sebco" and are focused on sepsis management, antimicrobial therapy, and subcutaneous injection techniques.